Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England
Vahé Nafilyan, Charlotte Bermingham, Isobel Ward, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England
Emma Copland, Martina Patone, Defne Saatci, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report
Kaatje Bollaerts, Chloé Wyndham-Thomas, Elizabeth Miller, et al.
Biologicals (2024) Vol. 85, pp. 101750-101750
Open Access | Times Cited: 10
Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies
Greg Marchand, Ahmed Taher Masoud, Sai Medi
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 19
Mortality risk after COVID-19 vaccination: A self-controlled case series study
Stanley Xu, Lina S. Sy, Vennis Hong, et al.
Vaccine (2024) Vol. 42, Iss. 7, pp. 1731-1737
Open Access | Times Cited: 6
Socioeconomic and temporal heterogeneity in SARS-CoV-2 exposure and disease in England from May 2020 to February 2023
Christian Morgenstern, Thomas Rawson, Wes Hinsley, et al.
Science Advances (2025) Vol. 11, Iss. 21
Open Access
An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine
Siying Hu, Dan Luo, Qikui Zhu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Unveiling the Interplay—Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2
Sunil J. Wimalawansa
Biology (2024) Vol. 13, Iss. 10, pp. 831-831
Open Access | Times Cited: 3
Vitamin D Deficiency Meets Hill’s Criteria for Causation in SARS-CoV-2 Susceptibility, Complications, and Mortality: A Systematic Review
Sunil J. Wimalawansa
Nutrients (2025) Vol. 17, Iss. 3, pp. 599-599
Open Access
Pfizer COVID19 vaccine is not associated with acute cardiovascular events excluding myocarditis– a national self-controlled case series study
Lital Keinan‐Boker, Ronen Fluss, Rita Dichtiar, et al.
Israel Journal of Health Policy Research (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study
Wataru Mimura, Chieko Ishiguro, Megumi Maeda, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Risk of death and cardiovascular events following COVID-19 vaccination or positive SARS-CoV-2 test amongst adult Singaporeans during omicron transmission
Liang En Wee, Muhammad Ismail Bin Abdul Malek, Janice Ser Huey Tan, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126356-126356
Closed Access | Times Cited: 2
Immunology of coronary atherosclerosis and unexplained sudden death in the COVID-19 era
Dennis McGonagle, Sami Giryes
Autoimmunity Reviews (2024), pp. 103642-103642
Open Access | Times Cited: 2
Investigating mortality trends in Italy during the COVID-19 pandemic: life expectancy changes within provinces and vaccination campaign impact up to December 2022
Andrea Nova, Teresa Fazia, Luisa Bernardinelli
Public Health (2023) Vol. 225, pp. 168-175
Open Access | Times Cited: 3
Sex Differences in Serious Adverse Events Reported Following Booster Doses of COVID-19 Vaccination in Thailand: A Countrywide Nested Unmatched Case-Control Study
Chawisar Janekrongtham, Mariano Salazar, Pawinee Doung‐ngern
Vaccines (2023) Vol. 11, Iss. 12, pp. 1772-1772
Open Access | Times Cited: 3
Risk of cardiac arrhythmia and cardiac arrest after primary and booster COVID-19 vaccination in England: A self-controlled case series analysis
Julia Stowe, Heather Whitaker, Nick Andrews, et al.
Vaccine X (2023) Vol. 15, pp. 100418-100418
Open Access | Times Cited: 1
Prediction of new likely emergent amino acid point mutations from USA, UK, Italy, France, Brazil, and India SARS-CoV-2 variants: a possible source for more reliable cocktail coronavirus vaccine
Saganuwan Alhaji Saganuwan
RPS Pharmacy and Pharmacology Reports (2024) Vol. 3, Iss. 1
Open Access
Association of the Magnitude of Anti-SARS-CoV-2 Vaccine Side Effects with Sex, Allergy History, Chronic Diseases, Medication Intake, and SARS-CoV-2 Infection
Elias A. Said, Afnan Al-Rubkhi, Sanjay Jaju, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 104-104
Open Access
Efecto del COVID-19 en el patrón de mortalidad por edad en la NFL
José Antonio Martínez García, Laura Martínez
Revista Académica Internacional de Educación Física (2024) Vol. 4, Iss. 3, pp. 25-32
Open Access
How should coronaphobia Be conceptualized? Evaluating competing models of the COVID-19 Phobia Scale using confirmatory factor analysis
Andrew Lac
Journal of Psychiatric Research (2024) Vol. 178, pp. 164-172
Closed Access
Detailed review of mortality reported following COVID-19 vaccination in Victoria, Australia: 2021-2023
Ingrid Laemmle‐Ruff, Jesse J. Fryk, Priya Shenton, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126368-126368
Closed Access
Socioeconomic and temporal heterogeneity in SARS-CoV-2 exposure and disease in England from May 2020 to February 2023
Christian Morgenstern, Thomas Rawson, Wes Hinsley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
COVID-19 vaccination and short-term mortality risk: a nationwide self-controlled case series study in The Netherlands
Isabel Slurink, Annemarijn R. de Boer, Marc J. M. Bonten, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Covid-19: Study reports no significant increase in deaths after vaccination but raises questions over AstraZeneca’s vaccine
Elisabeth Mahase
BMJ (2023), pp. p741-p741
Closed Access | Times Cited: 1
Non-COVID Admissions to the ICU After COVID Vaccination: A Multicenter Study
Amarja Ashok Havaldar, Kaladhar Sheshala, Raman Kumar, et al.
Cureus (2024)
Open Access
Unravelling Myths: A Difference-In-Differences Analysis of Post-Vaccination Mortality in Italy During COVID-19
Graziella Bonanno, Marino De Luca
Social Indicators Research (2024)
Open Access
Page 1 - Next Page

Scroll to top